Search

Zai Lab Ltd ADR

Closed

SectorHealthcare

18.32 -1.82

Overview

Share price change

24h

Current

Min

18.26

Max

19.07

Key metrics

By Trading Economics

Income

-607K

-51M

Sales

-28M

100M

EPS

-0.46

Profit margin

-51.215

Employees

1,784

EBITDA

4.1M

-44M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+65.79% upside

Dividends

By Acuity

Next Earnings

6 sie 2026

Market Stats

By TradingEconomics

Market Cap

-279M

2.1B

Previous open

20.14

Previous close

18.32

News Sentiment

By Acuity

100%

0%

318 / 340 Ranking in Healthcare

Zai Lab Ltd ADR Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

28 lip 2026, 23:56 UTC

News

Coursera Inc announced a $100 million investment in LearnVector, enhancing its AI strategy. Shares are trading higher during after-market hours.

28 lip 2026, 23:52 UTC

News
Correlated Moves
Social Media

Apple Inc. shares are higher in after-market trading as the company surpasses a $5 trillion market capitalization ahead of its Q3 earnings report.

28 lip 2026, 23:52 UTC

Social Media
News

Avis Budget Group shares lower in after-market trading following second-quarter results that missed expectations, with EPS of $0.98 against estimates of $1.91.

28 lip 2026, 23:52 UTC

News
Social Media

Verra Mobility Corp announced a seven-year tolling services contract with Avis Budget Group. Shares rose sharply in after-market trading following the announcement.

28 lip 2026, 23:52 UTC

Social Media
News

Ford Motor Co reported Q2 earnings, with adjusted EPS of $0.42 and revenue of $48.3 billion. Shares rose significantly in after-market hours.

28 lip 2026, 23:52 UTC

News
Social Media

PPG Industries shares declined in after-market hours following mixed second-quarter results, with adjusted EPS of $2.23 falling short of estimates.

28 lip 2026, 23:52 UTC

News
Social Media
Correlated Moves

NVIDIA shares are higher in after-market hours as analysts cite low valuation relative to growth potential, suggesting a strong buying opportunity.

28 lip 2026, 23:52 UTC

Social Media
News

IONQ Inc has received regulatory approval for its acquisition of SkyWater Technology. Shares are lower in after-market hours despite the positive development.

28 lip 2026, 23:52 UTC

Correlated Moves
News

FormFactor and Keystone Microtech expand their strategic partnership to enhance manufacturing scalability for advanced probe card solutions. Shares rise in after-market trading.

28 lip 2026, 23:52 UTC

ETF Constituents
Correlated Moves
News
Social Media

Invesco QQQ Trust Series I is higher in after-market trading, supported by gains from Microsoft, Broadcom, Netflix, Amazon, and AMD amid ongoing market concerns.

28 lip 2026, 23:52 UTC

Social Media
News

September WTI Crude Oil futures rose above $82.50 after an Iranian missile attack on U.S. forces, boosting United States Oil Fund LP in after-market trading.

28 lip 2026, 23:52 UTC

News
Correlated Moves
ETF Constituents

Vanguard Information Technology ETF is trading higher in after-market hours, supported by strong performances from top holdings like Microsoft and AMD.

28 lip 2026, 23:52 UTC

Social Media
Correlated Moves
News

Advanced Micro Devices is higher in after-market hours, supported by GIGABYTE's plans for servers using AMD EPYC processors and positive social media sentiment.

28 lip 2026, 23:52 UTC

News
Social Media
Correlated Moves

Amazon.com Inc is higher in after-market hours, boosted by positive market sentiment and its exclusive streaming rights for NHL playoff games on Prime Video.

28 lip 2026, 23:51 UTC

News

Bloom Energy Corp reported second-quarter revenue of $1.07 billion and raised its 2026 revenue guidance, with shares trading higher in after-market hours.

28 lip 2026, 23:51 UTC

News
Social Media

BofA Securities maintained its Buy rating on Intel Corp with a $160 price target, as shares rise in after-market trading amid positive sentiment and options activity.

28 lip 2026, 23:51 UTC

News

Herc Holdings Inc reported strong Q2 results and raised full-year guidance, with shares trading higher in after-market hours.

28 lip 2026, 23:51 UTC

News
Correlated Moves

Concerns over competition from China and AI demand sustainability weigh on semiconductor stocks. Applied Materials shares are near unchanged in after-market hours.

28 lip 2026, 23:46 UTC

Correlated Moves
News

Matador Resources Co trades higher since Tuesday's close.

28 lip 2026, 23:42 UTC

Social Media
News

KLA Corp shares declined in after-hours trading despite reporting net income of $1.36 billion, as first-quarter guidance fell short of expectations.

28 lip 2026, 23:41 UTC

News
Social Media

Microsoft shares rise in after-market trading as investors await earnings report, with revenue expectations at $87.62 billion and EPS estimated at $4.24.

28 lip 2026, 23:41 UTC

Correlated Moves
News

Joby Aviation shares are lower in after-market trading following the announcement about outstanding warrants expiring in 2026, impacting stock liquidity.

28 lip 2026, 23:41 UTC

Correlated Moves
News

Western Digital Corp shares are higher in after-market trading, buoyed by a rise in Seagate Technology Holdings PLC and ongoing AI-driven data storage demand.

28 lip 2026, 23:41 UTC

Correlated Moves
News

Fuelcell Energy Inc. shares rise in after-market trading, driven by Bloom Energy's stock increase and the launch of new high-temperature fuel cell systems.

28 lip 2026, 23:41 UTC

Social Media
News

Seagate Technology Holdings reported strong fourth-quarter results, with adjusted EPS of $5.71 and revenue of $3.63 billion, driving shares higher in after-market hours.

28 lip 2026, 23:41 UTC

News

OPKO Health reported a narrowed net loss of $8.4 million and raised revenue guidance, but shares are lower in after-market hours following recent gains.

28 lip 2026, 23:41 UTC

News

Coinbase Global Inc shares are lower in after-market hours following the appointment of Rob Witoff as Chief Technology Officer to enhance AI initiatives.

28 lip 2026, 23:41 UTC

News

Netflix shares are higher in after-market hours following Canada's plan to eliminate a levy on streaming services, creating a more favorable environment for the industry.

28 lip 2026, 23:36 UTC

Correlated Moves
News

BX faces increased competition after BlackRock's $220 billion deal.

28 lip 2026, 23:36 UTC

News

Zillow Group faces a potential securities fraud class action lawsuit, leading shares to trade lower in after-market hours amid investor concerns.

Peer Comparison

Price change

Zai Lab Ltd ADR Forecast

Price Target

By TipRanks

65.79% upside

12 Months Forecast

Average 30.87 USD  65.79%

High 44 USD

Low 21.6 USD

Based on 3 Wall Street analysts offering 12 month price targets forZai Lab Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

3 ratings

2

Buy

1

Hold

0

Sell

Sentiment

By Acuity

318 / 340 Ranking in Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
help-icon Live chat